[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352655-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352655-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","etv7-promotes-5-fu-resistance-and-malignant-progression-through-cxcl1-induced-nets-formation-in-colorectal-cancer","ETV7 promotes 5-FU resistance and malignant progression through CXCL1-induced NETs formation in colorectal cancer","","Resistance to 5-fluorouracil (5-FU) remains a major challenge in colorectal cancer (CRC). ETV7 is significantly upregulated in CRC tissues and cell lines, and elevated expression correlates with poor prognosis. Functional assays show ETV7 increases CRC proliferation, invasion, and 5-FU resistance by transcriptionally upregulating CXCL1, which enhances neutrophil recruitment and NET formation. NET-enriched tumor microenvironments promote aggressiveness and chemoresistance, while CXCL1 inhibition or NET degradation attenuates ETV7-driven phenotypes in vitro and in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/etv7-promotes-5-fu-resistance-and-malignant-progression-through-cxcl1-induced-nets-formation-in-colorectal-cancer/352655/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/etv7-promotes-5-fu-resistance-and-malignant-progression-through-cxcl1-induced-nets-formation-in-colorectal-cancer/352655.png","ImageObject",300,407,{"name":42,"@type":43},"Kyle","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does ETV7 play in colorectal cancer treatment with 5-FU?","Question",{"text":63,"@type":64},"ETV7 is upregulated in CRC and its higher expression is linked to poor clinical prognosis. ETV7 enhances CRC cell proliferation, invasion, and resistance to 5-FU.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does ETV7 promote chemoresistance mechanistically?",{"text":68,"@type":64},"ETV7 transcriptionally upregulates CXCL1, which increases neutrophil recruitment and promotes formation of neutrophil extracellular traps (NETs). The NET-rich tumor microenvironment supports tumor aggressiveness and chemoresistance.",{"name":70,"@type":61,"acceptedAnswer":71},"Which interventions reduce the ETV7-driven malignant phenotypes?",{"text":72,"@type":64},"Pharmacological inhibition of CXCL1 or degradation of NETs effectively attenuates ETV7-driven malignant phenotypes in both in vitro and in vivo models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352655,1790173983,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","communications biology Article  \nA Nature Portfolio journal  \n[https://doi.org/10.1038/s42003-026-09976-2](https://doi.org/10.1038/s42003-026-09976-2)  \n\n| ETV7 promotes 5-FU resistance and malignant progression through CXCL1-induced NETs formation in\u003Cbr>colorectal cancer\u003Cbr> Check for updates |  |\n| --- | --- |\n| Shuang Mo1,4, Pei Xia 1,4, Yongrui Lv1,4, Lei Liu2, Shujin He1, Huabin Gao1, Lin Chen1, Jianqiang Wu 3 , Anjia Han 1  & Lixia Chen 1  |  |\n| Resistance to 5-ﬂuorouracil (5-FU) remains a major challenge in the treatment of colorectal cancer (CRC) . Here, we identify ETS variant transcription factor 7 (ETV7) as signiﬁcantly upregulated in CRC tissues and cell lines, with elevated expression associated with poor clinical prognosis. Functional assays demonstrate that ETV7 enhances CRC cell proliferation, invasion, and resistance to 5-FU. Mechanistically, ETV7 transcriptionally upregulates CXCL1, leading to increased neutrophil recruitment and enhanced formation of neutrophil extracellular traps (NETs) . The resulting NETsenriched tumor microenvironment promotes tumor aggressiveness and chemoresistance. Pharmacological inhibition of CXCL1 or degradation of NETs effectively attenuates ETV7-driven malignant phenotypesin vitro and in vivo. Collectively,theseﬁndings establish anETV7–CXCL1–NETs axis that contributes to 5-FU resistance in CRC and suggest that targeting this pathway may improve chemotherapy response. |  |\n| Colorectal cancer (CRC) remains a major global health burden, with high incidence and mortality largely attributable to tumor recurrence and resistance to systemic therapies1. 5-Fluorouracil (5-FU)-based chemotherapy continues to serve as a cornerstone in CRC treatment2. However, its clinical beneﬁts are frequently limited by the emergence of drug resistance2. Despite extensive efforts, the mechanisms driving chemoresistance in CRCare highly heterogeneous and incompletely understood, particularly those involving tumor–microenvironment interactions rather than tumorintrinsic alterations alone. This gap highlights the need to explore non–cell-autonomous regulatory mechanisms that contribute to therapeutic failure.\u003Cbr>ETS variant transcription factor 7 (ETV7), also known as TEL2 or TELB, is a member of the E26 transformation-speciﬁc (ETS) family of transcription factors3–5. ETS family members regulate the expression of genes involved in tumor initiation and progression, thereby inﬂuencing key biological processes such as cell proliferation, migration, cell cycle control, and angiogenesis6–8. Accumulating evidence indicates that ETV7 is aberrantly overexpressed in multiple malignancies5,7, including hematologic cancers5,as well as solid tumors such as breast cancer9, bladder cancer10, and | melanoma8. In recent years, increasing attention has been directed toward the role of ETV7 in cancer progression and therapeutic resistance6. For instance, in breast cancer, ETV7 has been shown to maintain tumor cell stemness, thereby reducing cellular sensitivity to 5-FU and radiotherapy4. Moreover, emerging studies suggest that ETV7 participatesin the regulation of the tumor immune microenvironment9, 11. Notably, ETV7 has been reported to impair the antiviral and antitumor functions of CD8⁺ T cells by promoting their differentiation toward an exhausted phenotype8. In colorectal cancer, however, investigations into the biological function of ETV7 remain limited7. Collectively, current evidence links ETV7 to malignant progression and treatment resistance across multiple tumor types, although the precise molecular mechanisms underlying its effects require further elucidation.\u003Cbr>Neutrophils are increasingly recognized as critical regulators of tumor progression12. One of their key functional outputs is the formation of neutrophil extracellular traps (NETs)13, which consist of extracellular DNA ﬁbers associated with histones and granular proteins14. Originally characterized as an antimicrobial defense mechanism, NETs are now und","cbCainEbtEEkSc5j","https://ap.wps.com/l/cbCainEbtEEkSc5j","pdf",4667218,12,"English","# Background\n## Colorectal cancer and 5-FU resistance\n## ETV7 in cancer and immune regulation\n## Neutrophil extracellular traps (NETs)\n# Mechanistic Rationale\n## CXCL1 in neutrophil recruitment and activation\n## Linking CXCL1 to NETs-mediated chemoresistance\n# Central Findings (from the abstract)\n## ETV7 upregulation and clinical correlation\n## ETV7 enhances malignant phenotypes and 5-FU resistance\n## ETV7–CXCL1 axis and NET formation\n## Therapeutic attenuation by CXCL1 inhibition or NET degradation","[{\"question\":\"What role does ETV7 play in colorectal cancer treatment with 5-FU?\",\"answer\":\"ETV7 is upregulated in CRC and its higher expression is linked to poor clinical prognosis. ETV7 enhances CRC cell proliferation, invasion, and resistance to 5-FU.\"},{\"question\":\"How does ETV7 promote chemoresistance mechanistically?\",\"answer\":\"ETV7 transcriptionally upregulates CXCL1, which increases neutrophil recruitment and promotes formation of neutrophil extracellular traps (NETs). The NET-rich tumor microenvironment supports tumor aggressiveness and chemoresistance.\"},{\"question\":\"Which interventions reduce the ETV7-driven malignant phenotypes?\",\"answer\":\"Pharmacological inhibition of CXCL1 or degradation of NETs effectively attenuates ETV7-driven malignant phenotypes in both in vitro and in vivo models.\"}]","ETV7 promotes 5-FU resistance and malignant progression through CXCL1-induced NETs formation in colorectal cancer | PDF",1790100664,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f5d13488cde0eb35bd5ea6436027a8a.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36d215e853a56e883c063807e905e424.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dde5ad2a6f7a67b4f9f25f6e71a88cc2.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b5a435673376fe1b3032bc9ee888b71.webp",980,1301]